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Abstract
Physical as well as psychological features might be important prognostic factors for residual complaints following lumbar disc surgery in
primary care. No studies have yet investigated both factors simultaneously. The aim of this prospective cohort study was to identify
indicators of the short and long-term outcome of residual complaints following lumbar disc surgery. Patients (nZ105), aged between 18 and
65 years, were included if they still suffered residual complaints 6 weeks after first-time lumbar disc surgery and had therefore been referred
to physiotherapy. All potential indicators were measured at baseline except treatment expectancy, which was measured after two treatment
sessions enabling patients to rate treatment expectancy based on their actual perception of the treatment. Dimensions of recovery included
perceived recovery, functional status, and pain intensity (back and leg) at the 3-month and 12-month follow-up. It was found that high
treatment expectancy was associated with a favorable outcome on perceived recovery and functional status, both at the 3 and the 12-month
follow-up. Taking pain medication and a poor functional status at baseline were associated with poor perceived recovery and functional
status at both follow-up measurements. Leg pain and back pain at baseline were associated with residual leg and back pain at the 3 and the
12-month follow-up, respectively. The results for perceived recovery and functional status were rather robust. However, for leg pain and back
pain, the results were less stable. Apparently, the clinical course to recovery of residual leg pain and residual back pain is not strongly
influenced by these indicators.
q 2004 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.
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The occurrence of residual complaints following lumbar
disc surgery ranges from 22% to 45% and 30% to 70% of
patients report residual sciatica and residual low back pain,
respectively, after surgery (Dvorak et al., 1988; Hurme and
Alaranta, 1987; Korres et al., 1992; Manniche et al., 1994a,
b; Pappas et al., 1992; Weber, 1983; Yorimitsu et al., 2001).
The duration and intensity of the post-surgery rehabilitation
varies widely, but intensive exercise programs seem to be
the most effective (Ostelo et al., 2003b). The rehabilitation
of these patients takes place predominantly in a primary
care setting. Identifying prognostic factors that predict0304-3959/$20.00 q 2004 International Association for the Study of Pain. Publi
doi:10.1016/j.pain.2004.12.021
* Corresponding author. Tel.: C31 20 4448149; fax: C31 20 4448181.
E-mail address: r.ostelo@vumc.nl (R.W.J.G. Ostelo).the clinical course of residual complaints might be
important for the further development of effective methods
of treatment, especially when these prognostic factors can
be modified.
In primary care, some prognostic factors are routinely
included in history-taking, for example age, gender, and
severity of pain. Physical features such as height and weight,
and the activities of daily life (ADL) have been reported to
be important in predicting improvement in functional status
(Hurme and Alaranta, 1987). Additionally, psychological
factors might also influence the clinical course of residual
complaints. Kjelby-Wendt (Kjellby- Wendt et al., 1999)
reported that patients who became more discontented 3
and 12 months after the surgery were more depressed,
more anxious, and had experienced more pain before
the surgery. Psychological factors, in particular, could be
influenced by the fact that a patient underwent surgery.Pain 114 (2005) 177–185www.elsevier.com/locate/painshed by Elsevier B.V. All rights reserved.
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influence of these psychological factors on post-surgery
measurements. In analogy with the etiology of chronic low
back pain (Fritz et al., 2001; Vlaeyen and Linton, 2000), it
can be hypothesized that an excessively negative orientation
toward pain (pain catastrophizing) and fear of movement/
(re-)injury (kinesiophobia) after the surgery have an
important influence on the development or maintenance of
residual complaints following surgery. The mechanism has
been described as follows (Picavet et al., 2002): “Persons
who catastrophically misinterpret innocuous bodily sen-
sations, including pain, are likely to become fearful of pain,
which results in at least two processes. First, pain-related
fear is associated with avoidance behaviors and the
avoidance of movement and physical activity in particular.
Second, pain-related fear is associated with increased bodily
awareness and pain hypervigilance. Hypervigilance,
depression, and disuse are known to be associated with
increased pain levels and hence might exacerbate the painful
experience”.
The patient’s treatment expectations also seem to be
important in predicting outcomes in low back pain
(Kalauokalani et al., 2001) as well as the outcomes of
surgery for sciatica (Lutz et al., 1999). However, it is
unknown whether fear-avoidance beliefs, kinesiophobia and
the patient’s treatment expectations are factors that
influence the clinical course following lumbar disc surgery.
Moreover, as far as we know, no studies have yet
investigated physical and psychological factors simul-
taneously. Primary care physicians (e.g. physiotherapists,
general practitioners) can relatively easily assess these
variables by history-taking or by the use of short
questionnaires.
The aim of this prospective study is to investigate
whether the findings of history-taking, physical factors,
psychological assessment and the patient’s treatment
expectations predict the course of residual complaints
during rehabilitation following lumbar disc surgery.2. Materials and methods
2.1. Design
Our prospective study was conducted within the framework of a
randomized controlled trial on the effectiveness of usual care
provided by physiotherapists, compared to a behavioral graded
activity (BGA) program (Ostelo et al., 2003a). Both methods of
treatment, delivered in primary care, consisted of 18, 30-min
sessions within 3 months. Usual physiotherapeutic care consisted
of exercises to increase muscle strength, stability and mobility in
order to improve ADL. The patients were also instructed how to
lift, sit, and stand in the right way and how to perform various kinds
of ADL. If necessary, the therapists were allowed to apply
electrotherapy, massage or manipulations. The BGA program,
consisted of operant treatment, using graded activity and positive
reinforcement to increase health behaviors and decrease painbehaviors, based on time-contingency management. The essence
of the BGA was to establish an individually tailored exercise
program with increasing intensity, based on the measurements on
intake. The physical therapists underwent a 2-day training session,
and they received follow-up training during the course of the trial.
In the current study these interventions were not considered to be
prognostic indicators, but were adjusted for in all analyses.
2.2. Subjects
The neurosurgeon in each of the four participating hospitals in
the south of The Netherlands recruited the patients during the
routine from 6-weeks post-surgery visits. Patients (aged between
18 and 65 years) were included at the time of this visit if they still
suffered from residual complaints (severe back or leg pain and/or
restrictions in ADL and/or work) that justified a referral to
physiotherapy. This resembles the standard procedures adhered to
in the participating hospitals. Patients were excluded if there had
been complications during surgery, if they had a confirmed
and relevant underlying disease (e.g. stenosis or M. Bechterew), or
if one of the treatments was contraindicated. The Medical
Ethics Committee of the University Hospital Maastricht (The
Netherlands) approved the study protocol.
2.3. Baseline measurements
At baseline, i.e. before the first treatment session the following
potential prognostic indicators were measured: gender, age,
duration of complaints before surgery, whether or not (pain)me-
dication was taken at baseline because of the residual complaints,
number of days in hospital following the surgery, body mass index
(BMI), severity of pain in back and leg (both on a VAS), pain
catastrophizing (Pain Catastrophizing Scale, PCS) (Sullivan et al.,
1995), fear of movement (Tampa Scale for Kinesiophobia, TSK)
(Kori et al., 1990) and negative affectivity (Negative Emotionality
sub-scale of the Multidimensional Personality Questionnaire)
(Stegen et al., 1998; Tellegen, 1982). Finally, at baseline, the
patients rated their confidence in recovery in general (‘great deal’,
‘moderate’, ‘no confidence’ and ‘do not know’). This last variable
seems to have high face validity, and was therefore included to
assess its predictive power. The patient’s treatment expectancy
(11-point Likert scale: 0Zexpects no benefit at all, 10Zabsolutely
convinced of benefit) was the only variable that was not measured
at baseline but after two treatment sessions. The reason for this was
to enable patients to rate their expectations based on their actual
perception of the treatment, and not simply their assumptions
(Vlaeyen et al. 1996).
2.4. Dimensions of recovery
For patients with residual complaints following lumbar disc
surgery, several dimensions of recovery are frequently reported:
perceived recovery, functional status, and pain intensity (back
and leg).
Therefore, the following questionnaires, completed by the
patients themselves, were administered during the 3 (post-
treatment) and 12-month follow-up measurements.(1) Patients rated their perceived recovery on a 7-point ordinal
transition scale, ranging from ‘completely recovered’ to
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‘completely recovered’ or ‘much improved’, as reported by
the patient.(2) The Roland-Disability Questionnaire (RDQ) measured func-
tional status (Roland and Morris, 1983). A priori recovery was
defined as an RDQ score of %4. As this is a somewhat
arbitrary cut-off score, we performed sensitivity analyses with
different RDQ cut-off values (%3 and %5), in order to assess
the robustness of the findings.(3) Severity of back and leg pain (average pain previous week)
was scored on a VAS. A priori recovery was defined as a VAS
score of %10 mm. Again, a sensitivity analysis was
performed, using a cut-off value of %20 mm, to assess the
robustness of the findings.Table 1
Number of patients who had recovered at 3 and 12 months and the various
dimensions of recovery
Outcomes Recovered (n) Success rate (%)
Perceived recovery
3 Months 59 56.2
12 Months 74 70.5
Functional status (RDQ-score: %4)
3 Months 39 37.1
12 Months 46 43.8
Leg paina (VAS-score: %10 mm)
3 Months 43 41.0
12 Months 52 49.5
Back paina (VAS-score: %10 mm)
3 Months 31 29.5
12 Months 46 43.8
RDQ, Roland Disability Questionnaire; VAS, Visual Analogue Scale.
a Average pain previous week.2.5. Statistical analysis
First, the relationship between each potential prognostic
indicator and the outcome at issue was individually evaluated for
the short-term and the long-term separately, using logistic
regression and only adjusting for intervention. Odds Ratios
(ORs) and 95% confidence interval (CI) were calculated for each
dimension of recovery, to reflect the strength of the association.
Variables showing a promising relationship (P-value %0.25) were
included in the multivariate logistic regression. Subsequently a
backward elimination (P-value %0.10) was applied retaining only
those variables that were strongly associated with the outcome at
issue. The proportion of explained variance (Nagelkerke R2) and
the percentage of correctly classified patients are presented to give
an indication of the predictive power of the model. A patient was
considered to be classified correctly if the predicted probability
(according to the prognostic model) of being in the observed group
(recovered versus not recovered for the outcome measure at issue)
was more than 0.5. Occasional missing values in the prognostic
indicators at baseline (!5%) were replaced by their group means.
If patients did not attend a follow-up measurement, or dropped
out of the study completely, the reason for this was taken into
account in the replacement of the missing values. We think that this
procedure best anticipates the information at our disposal. The
reasons for not attending the measurement were registered by the
research assistant, who was blinded for the treatment allocation
and performed all measurements. Then three senior epidemiolo-
gists, also blinded for the treatment allocation, evaluated these
reasons per patient independently, based on pre-set criteria, and
decided whether the patient should be considered to have
‘recovered’ or ‘deteriorated’. Patients were considered to have
‘recovered’ if they could not attend a measurement because, for
example, they had returned to work completely and were therefore
no longer willing (or able) to attend the measurements. Patients
were considered to have ‘deteriorated’ if they did not attend a
measurement because they had more pain and consequently no
longer wished to participate in the study. Patients were also
considered to have ‘deteriorated’ if the neurosurgeon advised that
the treatment should be stopped because of strong indications of a
(new) herniated disc. If patients could not be considered to have
‘improved’ or ‘deteriorated’, and if there was no association with
the allocated treatment (e.g. the patient moved out of the catchment
area), missing values were replaced by mean scores. For the
substitution of ‘improved’ or ‘deteriorated’ we used the 10th or
90th percentile score of the total group. For example, the 10thpercentile was used to substitute low RDQ because these low RDQ
scores indicate a low level of disability, and the 90th percentile was
used to substitute the SF-36 sub-scales because high scores
indicate a good health status.3. Results
From November 1997 until December 1999 a total of 671
patients were checked for eligibility during their routine
6 weeks post-surgery visit to the neurosurgeon. Fifty-seven
percent of the patients had more or less recovered (no
further symptoms). One hundred and forty one patients
(21%) were excluded for various reasons: although operated
in a participating hospital, not living in the catchment
area (nZ40), not motivated to participate (nZ32), too old
(nZ30), presented with co-morbidities (nZ22), language
problems (nZ8), previous lumbar surgery (nZ7), and
insurance problems (nZ2). We failed to trace 43 patients
(6%). In total, 105 (16%) patients had been referred to
physiotherapy because of the residual complaints and were
eligible for participation. After receiving all information
regarding the study the participants signed informed
consent. At the 3-month measurement, eight patients
dropped out. The replacement procedure yielded three
mean substitutions, three positive substitutions, and two
negative substitutions. At the 12-month follow-up, another
four patients dropped out; two negative and two mean
substitutions. Table 1 presents the number of patients who
were considered to have recovered at 3 and 12 months.3.1. Perceived recovery
Table 2 presents the prognostic indicators of perceived
recovery.
Taking pain medication, poor functional status, high
levels of negative affectivity and low treatment expectancy
were associated with poor perceived recovery at the 3-month
Table 2
Prognostic indicators of perceived recovery
Variable 3 Months 12 Months
Individual indicators Multiple regression Individual indicators Multiple regression
OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Gender (female) (nZ45) 1.28 0.57; 2.87 0.50 0.21; 1.19*
Age (R43)a 0.49 0.21; 1.10* 0.57 0.24; 1.35*
Duration of complaints before surgery
(1) R2–%6 months (nZ56) 1.00 1.00
(2) R7–%12 months (nZ40) 1.15 0.49; 2.66 0.97 0.39; 2.41
(3) O12 months (nZ9) 0.38 0.08; 1.74* 0.30 0.07; 1.24*
Medication at baseline (yes) (nZ38) 0.49 0.21; 1.11* 0.52 0.24; 1.14 0.40 0.17; 0.94* 0.45 0.20; 0.99
Days in hospital (O7 days) (nZ28) 0.76 0.31; 1.87 1.75 0.63; 4.88
Body mass index
(1) !25 (nZ43) 1.00 1.00
(2) R25, !30 (nZ47) 0.59 0.25; 1.41 1.26 0.51; 3.11
(3) R30 (nZ15) 0.64 0.19; 2.16 1.32 0.36; 4.90
Functional status (RDQ O13)a 0.36 0.15; 0.83* 0.46 0.21; 1.00 0.30 0.11; 0.80* 0.40 0.17; 0.96
Pain back (VAS O45)a 0.66 0.30; 1.47 1.02 0.44; 2.38
Pan leg (VAS O43)a 0.56 0.25; 1.24* 0.73 0.32; 1.70
Fear of movement (TSK O40) (nZ77) 1.26 0.51; 3.09 1.10 0.41; 2.75
Catastrophizing (PCS)
(1) %11 1.00 1.00
(2) O11–%21 0.62 0.23; 1.64 0.90 0.30; 2.75
(3) O21 0.51 0.20; 1.38* 0.35 0.12; 0.98*
Negative affectivity (NEM)
(1) %1 1.00 1.00
(2) O1–%4 0.63 0.24; 1.66 0.63 0.26; 1.55 0.62 0.22; 1.78
(3) O4 0.34 0.27; 0.94* 0.38 0.16; 0.93 0.46 0.16; 1.34
Confidence in recovery in general
(1) Great deal (nZ43) 1.00 1.00
(2) Moderate (nZ42) 1.63 0.65; 4.09 1.26 0.48; 3.36
(3) No confidence (nZ6) 0.13 0.01; 1.26* 0.39 0.07; 2.20
(4) Do not know (nZ14) 0.30 0.08; 1.11* 0.49 0.14; 1.74
Patients’ treatment expectancy (R6)
(nZ80)
3.78 1.40; 10.21* 3.11 1.30; 7.48 3.54 1.27; 9.88* 2.52 1.09; 5.87
Nagelkerke R2 0.233 0.151
Correctly classified (0.500) 69.5% 69.5%
Odds Ratios (OR) and 95% Confidence Interval (CI) for each indicator. All analyses adjusted for intervention. *P-value %0.250 for individual indicator,
included in multivariate logistic regression. Variables with more than two categories were included if only one category had a P-value %0.250. In multivariate
logistic regression only variables with P-value %0.10. RDQ, Roland Disability Questionnaire; VAS, Visual Analogue Scale; TSK, Tampa Scale for
Kinesiophobia; PCS, Pain Catastrophizing Scale, NEM, Negative Emotionality subscale.
a Cut-off valueZmedian, for all other variables numbers in categories between brackets. For dichotomous variables the reference category is the contrast
(female versus male), for all other variables the reference category is first category (ORZ1).
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rather similar: only negative affectivity was no longer
associated with perceived recovery. The overall predictive
power of the models was only modest; Nagelkerke R2 was
0.233 and 0.151 for 3 and 12 months, respectively. The
percentage of correctly classified patients was 69.5% for
both follow-up measurements.3.2. Functional status
Table 3 presents the prognostic indicators of functional
status.
Taking pain medication, a poor functional status, a
high BMI and a low treatment expectancy were associatedwith poor recovery of functional status at the 3-month
follow-up. The results for the 12-month follow-up were
rather similar, except that a high BMI was no longer
associated with poor recovery. ‘Confidence in recovery in
general’ (‘no confidence’ and ‘do not know’), was now
associated with poor recovery. The explained variance
(Nagelkerke R2) was 0.318 and 0.345 for 3 and 12
months, respectively. The percentage of patients correctly
classified by the models was 73.3 and 75.2% for the 3 and
12-month follow-up, respectively. These results were
rather robust: different RDQ values (%3 and %5) only
revealed that ‘confidence in recovery in general’ was no
longer associated with the 12-month follow-up based on
an RDQ score %5.
Table 3
Prognostic indicators of functional status (recovered: RDQ score %4)
Variable 3 Months 12 Months
Individual indicators Multiple regression Individual indicators Multiple regression
OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Functional status (RDQ O13)a 0.21 0.09; 0.49* 0.26 0.10; 0.67 0.25 0.11; 0.59* 0.49 0.19; 1.29
Gender (female) (nZ45) 1.08 0.48; 2.43 0.56 0.25; 1.24*
Age (R43)a 0.59 0.26; 1.33* 0.80 0.37; 1.74
Duration of complaints before surgery
(1) R2–%6 months (nZ56) 1 1
(2) R7–%12 months (nZ40) 1.16 0.49; 2.57 0.95 0.42; 2.14
(3) O12 months (nZ9) 0.48 0.09; 2.55 0.33 0.06; 1.74*
Medication at baseline (yes) (nZ38) 0.25 0.10; 0.64* 0.25 0.09; 0.73 0.16 0.06; 0.42* 0.15 0.05; 0.43
Days in hospital (O7 days) (nZ28) 0.89 0.36; 2.21 1.14 0.47; 2.73
Body mass index
(1) !25 (nZ43) 1 1 1
(2) R25, !30 (nZ47) 0.53 0.22; 1.27* 0.35 0.12; 0.99 0.71 0.31; 1.63
(3) R30 (nZ15) 0.83 0.25; 2.76 0.79 0.21; 2.94 0.70 0.21; 2.29
Pain back (VAS O45)a 0.92 0.41; 2.03 0.80 0.37; 1.74
Pan leg (VAS O43)a 0.79 0.36; 1.76 0.55 0.25; 1.20*
Fear of movement (TSK O40) (nZ77) 0.91 0.37; 2.25 0.63 0.26; 1.54
Catastrophizing (PCS)
(1) %11 1 1
(2) O11–%21 0.31 0.11; 0.84* 0.54 0.21; 1.38*
(3) O21 0.35 0.13; 0.94* 0.36 0.14; 0.96*
Negative affectivity (NEM)
(1) %1 1 1
(2) O1–%4 0.46 0.17; 1.20* 0.75 0.30; 1.90*
(3) O4 0.49 0.18; 1.32* 0.50 0.19; 1.33*
Confidence in recovery
(1) Great deal (nZ43) 1 1 1
(2) Moderate (nZ42) 0.88 0.37; 2.11 0.50 0.21; 1.18* 0.80 0.29; 2.18
(3) No confidence (nZ6) 0.25 0.03; 2.35 0.14 0.02; 1.34* 0.24 0.02; 2.63
(4) Do not know (nZ14) 0.19 0.04; 3.29 0.19 0.05; 0.78* 0.22 0.05; 1.12
Patients’ treatment expectancy (R6) (nZ80) 2.94 1.00; 8.64* 4.22 1.23; 14.42 2.44 0.92; 6.48* 3.03 0.98; 9.39
Nagelkerke R2 0.318 0.345
Correctly classified (0.500) 73.3% 75.2%
Odds Ratios (OR) and 95% Confidence Interval (CI) for each indicator. All analyses adjusted for intervention. *P-value %0.250 for individual indicator,
included in multivariate logistic regression. Variables with more than two categories were included if only one category had a P-value %0.250. In multivariate
logistic regression only variables with P-value %0.10. RDQ, Roland Disability Questionnaire; VAS, Visual Analogue Scale; TSK, Tampa Scale for
Kinesiophobia; PCS, Pain Catastrophizing Scale; NEM, Negative Emotionality sub-scale.
a Cut-off valueZmedian, for all other variables numbers in categories between brackets. For dichotomous variables the reference category is the contrast
(female versus male), for all other variables the reference category is first category (ORZ1).
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With respect to predictors of the severity of back pain,
Table 4 shows that the intensity of back pain at baseline was
associated with a poor outcome on back pain at the 3 and
12-month follow-up. Taking pain medication at baseline
and negative affectivity were only associated with poor
outcome at the 3-month follow-up, whereas poor functional
status (RDQ O13) and leg pain at baseline were only
associated with poor outcome at the 12-month follow-up.
The overall predictive power of the models was modest,
with an explained variance (Nagelkerke R2) of 0.297 and
0.143 for 3 and 12 months, respectively. The percentage of
patients who were correctly classified by the models was
77.1 and 64.8% for the 3 and 12-month follow-up,respectively. The sensitivity analysis showed that using
a cut-off value of %20 mm altered the results. Negative
affectivity was no longer associated with back pain at the
3-month follow-up, but was replaced by treatment expect-
ancy. At the 12-month follow-up ‘RDQO13’ was replaced
by pain catastrophizing. However, the overall predictive
power of the model did not change substantially, and
remained modest.3.4. Leg pain
Table 5 shows that both leg pain at baseline and a poor
functional status (RDQO13) at baseline were associated
with a poor outcome for leg pain at the 3 and 12-month
follow-up. In addition, high treatment expectancy was
Table 4
Prognostic indicators of back-pain (recovered: VAS score %10 mm)
Variable 3 Months 12 Months
Individual indicators Multiple regression Individual indicators Multiple regression
OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Pain back (VAS O45)a 0.21 0.08; 0.52* 0.24 0.09; 0.63 0.69 0.32; 1.50 0.72 0.31; 1.65
Functional status (RDQ O13)a 0.42 0.17; 1.00* 0.32 0.14; 0.72* 0.35 0.15; 0.81
Gender (female) (nZ45) 0.63 0.26; 1.51 0.67 0.30; 1.48
Age (R43)a 0.38 0.16; 0.93* 0.57 0.26; 1.25*
Duration of complaints before surgery
(1) R2–%6 months (nZ56) 1 1
(2) R7–%12 months (nZ40) 0.80 0.33; 1.95 1.90 0.84; 4.34*
(3) O12 months (nZ9) 0.58 0.11; 3.17 0.45 0.09; 2.37
Medication at baseline (yes) (nZ38) 0.31 0.11; 0.85* 0.28 0.10; 0.85 0.45 0.20; 1.04*
Days in hospital (O7 days) (nZ28) 0.75 0.28; 2.00 0.74 0.31; 1.81
Body mass index
(1) !25 (nZ43) 1 1
(2) R25, !30 (nZ47) 1.37 0.55; 3.43 1.23 0.53; 5.67
(3) R30 (nZ15) 1.46 0.41; 5.24 1.73 0.53; 5.67
Pain leg (VAS O43)a 0.79 0.34; 1.83 0.46 0.21; 1.02* 0.47 0.20; 1.08
Fear of movement (TSK O40) (nZ77) 0.57 0.21; 1.58 0.77 0.32; 1.86
Catastrophizing (PCS)
(1) %11 1 1
(2) O11–%21 0.61 0.27; 1.63 0.76 0.30; 1.95
(3) O21 0.32 0.11; 0.95* 0.35 0.13; 0.94*
Negative affectivity (NEM)
(1) %1 1 1 1
(2) O1–%4 0.46 0.17; 1.22* 0.55 0.19; 1.61 0.93 0.37; 2.34
(3) O4 0.16 0.05; 0.56* 0.21 0.06; 0.78 0.57 0.21; 1.50*
Confidence in recovery
(1) Great deal (nZ43) 1 1
(2) Moderate (nZ42) 0.49 0.20; 1.23* 0.55 0.23; 0.30*
(3) No confidence (nZ6) 0.28 0.03; 2.59* 0.43 0.07; 2.64
(4) Do not know (nZ14) 0.11 0.01; 0.90* 0.45 0.13; 1.60*
Patients’ treatment expectancy (R6) (nZ80) 3.97 1.09; 14.46* 1.52 0.60; 3.84
Nagelkerke R2 0.297 0.143
Correctly classified (0.500) 77.1% 64.8%
Odds Ratios (OR) and 95% Confidence Interval (CI) for each indicator. All analyses adjusted for intervention. *P-value %0.250 for individual indicator,
included in multivariate logistic regression. Variables with more than two categories were included if only one category had a P-value %0.250. In multivariate
logistic regression only variables with P-value %0.10. RDQ, Roland Disability Questionnaire; VAS, Visual Analogue Scale; TSK, Tampa Scale for
Kinesiophobia; PCS, Pain Catastrophizing Scale, NEM, Negative Emotionality sub-scale.
a Cut-off valueZmedian, for all other variables numbers in categories between brackets. For dichotomous variables the reference category is the contrast
(female versus male), for all other variables the reference category is first category (ORZ1).
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3-month follow-up.
The overall predictive power of the models was
modest: Nagelkerke R2 of 0.226 and 0.197 for 3 and 12
months, respectively. The percentage of patients who
were correctly classified was 68.6 and 69.5% for the 3 and
12-month follow-up, respectively. As with back pain, a
cut-off value of %20 mm altered the results slightly. At
the 3-months follow-up only leg pain at baseline was
retained in the multivariate model. At the 12-month
follow-up treatment expectancy was no longer retained in
the multivariate model. Also, as with back pain, the
overall predictive power did not change substantially, and
remained modest.4. Discussion
The aim of our study was to identify indicators of the
short and long-term outcome of residual complaints
following lumbar disc surgery that can easily be measured
in primary care. Not surprisingly, baseline scores for the
outcome measures are strong predictors of the respective
outcomes of the 3 and 12-month follow-up measurements.
Poor functional status (RDQO13) at baseline was associ-
ated with a poor outcome on functional status, and the
baseline scores for leg pain and back pain predicted the
outcomes on leg pain and back pain, respectively. Taking
pain medication was associated with a poor outcome on
both follow-up measurements of perceived recovery
Table 5
Prognostic indicators of leg pain (recovered: VAS score %10 mm)
Variable 3 Months 12 Months
Individual indicators Multiple regression Individual indicators Multiple regression
OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Pan leg (VASO43)a 0.25 0.11; 0.58* 0.24 0.10; 0.58 0.38 0.17; 0.85* 0.38 0.16; 0.75
Pain back (VASO45)a 1.04 0.48; 2.28 1.44 0.66; 3.15
Functional status (RDQO13)a 0.40 0.18; 0.91* 0.45 0.18; 1.08 0.44 0.19; 0.98* 0.31 0.13; 0.75
Gender (female) (nZ45) 0.80 0.36; 1.77 1.04 0.47; 2.29
Age (R43)a 0.73 0.33; 1.61 1.05 0.48; 2.28
Duration of complaints before surgery
(1) R2–%6 months (nZ56) 1 1
(2) R7–%12 months (nZ40) 1.27 0.56; 2.88 1.01 0.45; 2.29
(3) O12 months (nZ9) 0.78 0.18; 3.43 0.83 0.20; 3.47
Medication at baseline (yes) (nZ38) 0.45 0.19; 1.04* 0.64 0.28; 1.44
Days in hospital (O7 days) (nZ28) 0.59 0.24; 1.48 0.77 0.32; 1.87
Body mass index
(1) !25 (nZ43) 1 1
(2) R25, !30 (nZ47) 1.36 0.59; 3.17 0.82 0.35; 1.89
(3) R30 (nZ15) 1.12 0.34; 3.75 0.56 0.17; 1.87
Fear of movement (TSKO40) (nZ77) 1.11 0.46; 2.67 1.00 0.42; 2.40
Catastrophizing (PCS)
(1) %11 1 1
(2) O11–%21 1.31 0.51; 3.35 1.11 0.43; 2.86
(3) O21 0.80 0.31; 2.09 0.51 0.20; 1.34*
Negative affectivity (NEM)
(1) %1 1 1
(2) O1–%4 0.67 0.26; 1.70 1.02 0.40; 2.58
(3) O4 0.55 0.21; 1.47* 0.78 0.30; 2.03
Confidence in recovery
(1) Great deal (nZ43) 1 1
(2) Moderate (nZ42) 0.59 0.25; 1.41* 0.51 0.21; 1.22*
(3) No confidence (nZ6) 0.91 0.02; 1.77* 0.65 0.12; 3.70
(4) Do not know (nZ14) 0.38 0.10; 1.40* 0.31 0.09; 1.12
Patients’ treatment expectancy (R6) (nZ80) 2.72 0.98; 7.54* 3.00 1.00; 9.00 1.32 0.53; 3.29
Nagelkerke R2 0.226 0.197
Predicted (0.500) 68.6% 69.5%
Odds Ratios (OR) and 95% Confidence Interval (CI) for each indicator. All analyses adjusted for intervention. *P-value %0.250 for individual indicator,
included in multivariate logistic regression. Variables with more than two categories were included if only one category had a P-value %0.250. In multivariate
logistic regression only variables with P-value %0.10. RDQ, Roland Disability Questionnaire; VAS, Visual Analogue Scale; TSK, Tampa Scale for
Kinesiophobia; PCS, Pain Catastrophizing Scale; NEM, Negative Emotionality sub-scale.
a Cut-off valueZmedian, for all other variables numbers in categories between brackets. For dichotomous variables the reference category is the contrast
(female versus male), for all other variables the reference category is first category (ORZ1).
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at the 3-month follow-up. Taking medication at baseline
seems to be an indicator of the severity of complaints,
because it was highly correlated with leg pain and a poor
functional status at baseline. Patients taking pain medication
had a statistically significant higher RDQ score (P!0.000),
and scored statistically significantly higher (PZ0.025) on
leg pain at baseline. The multivariate models revealed that
this indicator was highly significantly associated with
perceived recovery and functional status, also when
adjusted for leg pain and decreased functional status.
For functional status and perceived recovery at 3 and 12
months, and for leg pain at 3 months, a favorable prognosis
was found for patients with high treatment expectancy. It
has been reported that treatment expectancy is a significant
predictor of the outcome of treatment for anxiety disordersor depression (Kirsch and Sapirstein, 1999), in the
magnitude of the effect of placebo analgesia (Price et al.,
1999) and the outcome of conservative treatment for low
back pain (Kalauokalani et al., 2001). Moreover, treatment
expectancy predicts the outcome of surgical treatment for
sciatica (Lutz et al., 1999). The results of our study seem to
support these findings, but it should be noted that the overall
predictive power of the models was modest, at best. There
might be some overlap between treatment expectancy and
the patient’s ‘confidence in recovery in general’ but the
results show that the predictive value of both concepts is
rather different. We think that the main reason for this is that
treatment expectancy specifically focuses on the treatment,
and is based on actual perception, as opposed to ‘confidence
in recovery in general’. There is still no unambiguous
explanation for the effects treatment expectancy, and
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suggested that treatment expectancy is partly responsible for
the ‘non-specific’ effects of treatment (Deyo et al., 1990;
Luparello et al., 1970; Price et al., 1999). However, from a
methodological point of view there might be some concerns
with regard to the assessment of expectancy. As stated,
rating of treatment expectancy was based on the actual
perception of the treatment, because it was rated after the
first two treatment sessions. Therefore in our study
treatment expectancy includes two components: expectancy
with regard to the treatment effect and the patient–therapist
interaction. However, no psychometric properties have yet
been established for any of the methods used to assess
treatment expectancy. Recently Devilly (Devilly and
Borkovec, 2000) assessed the psychometric properties of
the credibility/expectancy questionnaire (CEQ), and
although they seem to be promising, the authors still stress
the need for caution using the scale.
Contrary to what we had anticipated, fear of movement
and pain-catastrophizing were not associated with any of the
dimensions of recovery. None of the univariate models
demonstrated a significance level of !0.250. Therefore,
these indicators were not included in the multivariate
models. A possible explanation could be that the TSK and
the PCS are not specifically focused on a post-surgery
population. This population might have fear of some very
specific movements, such as turning over in bed or lifting
heavy objects from the floor, whereas the TSK items only
relate to general activities. In other words, further research
is necessary to validate these measures in a post-surgery
population. In order to assess the robustness of the results
we re-analyzed our data using a cut-off value of O42 (as
opposed to 40). However, the different cut-off value made
no substantial change in the results.
It could be argued that measuring some variables pre-
operatively is important, but in this study we focused on
prognostic variables for residual complaints following
lumbar disc surgery. In our opinion, it is more appropriate
to measure post-operatively variables, such as fear of
movement and pain catastrophzing that are likely to be
altered by the surgery. Moreover, treatment expectancy was
rated after two treatment sessions because we think that it is
important that patients can rate their expectancy based on
their actual perception of the treatment, and not simply on
their assumptions. Initially, we also planned to include some
variables that were measured before the surgery (e.g. muscle
tendon reflexes, pain intensity) but due to practical problems
this was not possible. Measuring the Laseque was not
informative, because a positive pre-surgery Laseque was
one of the inclusion criteria for the surgery. To account for
the severity of the pre-surgery complaints, the duration of
complaints before surgery was included as a potential
indicator because this was measured by patient self-reports.
However, it was not found to be associated with any of the
outcomes in this study. The type of surgery was not included
in the analyses, because the majority of the patientsunderwent a standard discectomy. It is therefore not know
whether our results also apply to other types of surgery for
herniated lumbar discs, but as the standard discectomy is the
most frequently applied technique our study population
represents the majority of post lumbar disc surgery patients.
Our sample of patients was studied prospectively, so this
can be considered as a cohort study in which the
interventions are regarded as prognostic indicators. It
appeared that there were no differences between the two
intervention groups in either treatment expectations or
outcomes. Although there were no differences between the
two groups, the range within the outcome measures (as
indicated by relatively large SDs) was broad. However, the
range within treatment expectancy was narrow which might
have affected the predictive power of this measurement. If
there had been a broader range in treatment expectancy we
expect that the predictive power would have been stronger.
However, there are no indications that this narrow range in
scores in treatment expectancy is a result of the method of
patient recruitment. The inclusion and exclusion criteria for
our trial (and thus for referring patients to primary care
treatment) reflect the daily clinical practice of the
neurosurgeon during their 6 weeks consult. Therefore we
do not think that our sample was selected on the basis of
prognosis. Certainly not all patients with residual com-
plaints were referred by the neurosurgeon. The majority of
patients who were potentially eligible, but did not
participate in the study were excluded due to practical
reason, as described in the first paragraph of Section 3.
Therefore we think that a broad spectrum of patients with
residual complaints was included.
We used dichotomized outcome measures because we
focused on indicators for absolute recovery, and not just
improvement (or change) in pain or functional status.
However, the use of cut-off values is somewhat arbitrary, so
we performed sensitivity analyses in order to assess the
robustness of the results. For functional status the results
proved to be robust: using different RDQ scores (%3 and
%5) as cut-off values at follow-up yielded similar findings.
However, for leg pain and back pain, the results were less
stable. Using different cut-off values yielded different
multivariate models, but the overall predictive power of
the different models remained modest, at best. Apparently,
the clinical course to recovery of residual leg pain and
residual back pain is not strongly influenced by these
indicators.
Finally, the results of our study have some relevance for
application in primary care. First of all, a few indicators
could help health care providers to identify patients with a
higher risk, but more high quality studies are needed to
investigate a broad spectrum of potential indicators, because
the overall predictive value of the models was low.
Secondly, the role of treatment expectancy is interesting.
Our results lent some support to the assumption that, in
addition to being evidence based, interventions that are
offered to patients should preferably also meet the patient’s
R.W.J.G. Ostelo et al. / Pain 114 (2005) 177–185 185expectations, whenever possible. Moreover, health care
providers could play an important role in positively altering
a patient’s treatment expectancy. It has already been
demonstrated that treatment expectancy can be greatly
influenced by the amount and length of the information
provided, and also by the kind of language used to
communicate the information (Horvath, 1990; Kazdin and
Krouse, 1983).References
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